Diffusion magnetic resonance imaging detects pathologically confirmed, nonenhancing tumor progression in a patient with recurrent glioblastoma receiving bevacizumab.
作者信息
Gerstner Elizabeth R, Frosch Matthew P, Batchelor Tracy T
机构信息
Departments of Neurology and Pathology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA.
出版信息
J Clin Oncol. 2010 Feb 20;28(6):e91-3. doi: 10.1200/JCO.2009.25.0233. Epub 2009 Nov 23.
PMID:19933906
Abstract
摘要
Zotero 插件